Philip Morris targets two-thirds smoke-free revenue by 2030 but faces FDA fines for Zyn's underage sales.

Philip Morris International, led by CEO Jacek Olczak, aims to generate two-thirds of its revenue from smoke-free alternatives like Zyn nicotine pouches by 2030. Zyn sales in the U.S. are expected to reach 580 million tins this year, up from 385 million last year. However, the product's popularity has raised concerns as it has fallen into minors' hands, prompting regulatory actions and fines from the FDA.

3 months ago
21 Articles